Vardaman, Maya, Gilmour, Stuart · Journal of translational medicine · 2025 · DOI
This editorial letter addresses the need to correct how the global health burden of ME/CFS is measured and reported. The authors argue that current statistics may not fully capture how severely this illness affects patients worldwide. They emphasize that getting accurate numbers is important for raising awareness and securing resources for research and patient care.
Accurate measurement of ME/CFS's global health burden is critical for advocacy, research funding allocation, and clinical recognition. When diseases are undercounted or misrepresented in health statistics, patients receive fewer resources and less medical attention. This editorial helps highlight discrepancies that could lead to better policy decisions affecting millions of ME/CFS patients worldwide.
As an editorial letter, this work does not present new experimental data or conduct a systematic analysis of burden of disease metrics. It does not provide alternative quantitative estimates to replace current numbers, nor does it establish causation in any biological mechanisms. The conclusions are critical commentary rather than evidence-based findings from primary research.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →